Apoptotic and proliferation indexes in primary superficial bladder tumors.

[1]  R. Montironi,et al.  Ki-67 MIB1 labelling index and the prognosis of primary TaT1 urothelial cell carcinoma of the bladder , 2006, Journal of Clinical Pathology.

[2]  C. Rödel,et al.  Combined-Modality Treatment and Organ Preservation in Bladder Cancer , 2005, Strahlentherapie und Onkologie.

[3]  I. Sesterhenn,et al.  World health organization classifications of tumours. pathology and genetics of tumours of the urinary system and male genital organs , 2005 .

[4]  A. Lopez‐Beltran,et al.  Prognostic Factors in Survival of Patients With Stage Ta and T1 Bladder Urothelial Tumors , 2004 .

[5]  R. Montironi,et al.  Prognostic factors in survival of patients with stage Ta and T1 bladder urothelial tumors: the role of G1-S modulators (p53, p21Waf1, p27Kip1, cyclin D1, and cyclin D3), proliferation index, and clinicopathologic parameters. , 2004, American journal of clinical pathology.

[6]  K. Naito,et al.  Bax to Bcl-2 ratio and Ki-67 index are useful predictors of neoadjuvant chemoradiation therapy in bladder cancer. , 2004, Japanese journal of clinical oncology.

[7]  A. Borkowski,et al.  P27Kip1 and Ki-67 expression analysis in transitional cell carcinoma of the bladder , 2003, Urological Research.

[8]  J. Baak,et al.  Proliferation markers and DNA content analysis in urinary bladder TaT1 urothelial cell carcinomas: identification of subgroups with low and high stage progression risks , 2003, Journal of clinical pathology.

[9]  D. Bostwick,et al.  Classification and grading of the non-invasive urothelial neoplasms: recent advances and controversies , 2003, Journal of clinical pathology.

[10]  P. Humphrey,et al.  Patterns of multiple recurrences of superficial (Ta/T1) transitional cell carcinoma of bladder and effects of clinicopathologic and biochemical factors , 2002, Cancer.

[11]  A. Lazaris,et al.  Immunohistochemical study of pro-apoptotic factors Bax, Fas and CPP32 in urinary bladder cancer: prognostic implications , 2002, Urological Research.

[12]  A. Formiconi,et al.  Proliferative activity is the most significant predictor of recurrence in noninvasive papillary urothelial neoplasms of low malignant potential and grade 1 papillary carcinomas of the bladder , 2002, Cancer.

[13]  P. Korkolopoulou,et al.  Differential expression of bcl-2 family proteins in bladder carcinomas. Relationship with apoptotic rate and survival. , 2002, European urology.

[14]  A. Hart,et al.  Apoptosis, proliferation and p53, cyclin D1, and retinoblastoma gene expression in relation to radiation response in transitional cell carcinoma of the bladder. , 2001, International journal of radiation oncology, biology, physics.

[15]  F. Algaba,et al.  Primary superficial bladder cancer risk groups according to progression, mortality and recurrence. , 2000, The Journal of urology.

[16]  L. Lacombe,et al.  Can biological markers predict recurrence and progression of superficial bladder cancer? , 2000, Current opinion in urology.

[17]  A. Smeets,et al.  MIB‐1 as a proliferative marker in transitional cell carcinoma of the bladder , 2000, Cancer.

[18]  M. Droller,et al.  The natural history of bladder cancer. Implications for therapy. , 2000, The Urologic clinics of North America.

[19]  P. Lipponen,et al.  Prognostic Value of MIB-1 Score, p53, EGFr, Mitotic Index and Papillary Status in Primary Superficial (Stage pTa/T1) Bladder Cancer: A Prospective Comparative Study , 1999, European Urology.

[20]  P. Lara,et al.  Apoptosis in carcinoma of the bladder: relation with radiation treatment results. , 1999, International journal of radiation oncology, biology, physics.

[21]  A. Zlotta,et al.  Correlation and prognostic significance of p53, p21WAF1/CIP1 and Ki-67 expression in patients with superficial bladder tumors treated with bacillus Calmette-Guerin intravesical therapy. , 1999, The Journal of urology.

[22]  P. Humphrey,et al.  Invasion of the bladder by transitional cell carcinoma , 1998, Cancer.

[23]  M. Dimopoulos,et al.  The prevalence of bcl-2, p53, and Ki-67 immunoreactivity in transitional cell bladder carcinomas and their clinicopathologic correlates. , 1998, Human pathology.

[24]  P. Lipponen,et al.  Apoptosis in bladder cancer as related to standard prognostic factors and prognosis , 1994, The Journal of pathology.

[25]  A. Jemal,et al.  Cancer Statistics, 2005 , 2005, CA: a cancer journal for clinicians.

[26]  J. Cheville,et al.  Non-invasive urothelial tumours , 2004 .

[27]  N. Kyprianou,et al.  Incidence of apoptosis, cell proliferation and bcl-2 expression in transitional cell carcinoma of the bladder: association with tumor progression. , 1996, The Journal of urology.